US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

US IPOs and Secondary Offerings

Chagee Holdings Limited (CHA): International Investors to Dominate the IPO Order Book

Chagee Holdings Limited (CHA): IPO Valuation Highly Attractive Drawing Strong Interest on Day One

Chagee Holdings Limited (CHA): Peeking at the IPO Prospectus of China's Premium Tea Brand

IPOs and Secondary Offerings

Equity Capital Markets

<ul>
<li>Chinese Tea Company is moving ahead with the IPO despite heavy Macro-Economic winds.</li>
<li>The company is seeking up to $412m with a high-end pricing and already includes $205m worth of buying on the cover of the prospectus.</li>
<li>There are. more questions than answers regarding this IPO due to the current uncertainty in the market. </li>
</ul>


Chinese Tea Company is moving ahead with the IPO despite heavy Macro-Economic winds.
The company is seeking up to $412m with a high-end pricing and already includes $205m worth of buying on the cover of the prospectus.
There are. more questions than answers regarding this IPO due to the current uncertainty in the market. 


Chagee Holdings Limited (CHA): Chinese Tea Company Moves Forward with IPO Despite Macro Risks